Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,815
archived clinical trials in
Parkinsons Disease

The Stanford Parkinson's Disease Plasma Study
The Stanford Parkinson's Disease Plasma (SPDP) Study: Intravenously-Administered Plasma From Young Donors for Treatment of Moderate Parkinson's Disease
Status: Enrolling
Updated:  12/31/1969
Stanford Movement Disorders Clinic
mi
from
Stanford, CA
The Stanford Parkinson's Disease Plasma Study
The Stanford Parkinson's Disease Plasma (SPDP) Study: Intravenously-Administered Plasma From Young Donors for Treatment of Moderate Parkinson's Disease
Status: Enrolling
Updated: 12/31/1969
Stanford Movement Disorders Clinic
mi
from
Stanford, CA
Click here to add this to my saved trials
Parkinson's Autonomic Responses to Treadmill Walking
Assessment of Autonomic Function and Cardiovascular Response to Exercise Testing in Parkinson's Disease Patients
Status: Enrolling
Updated:  12/31/1969
Laboratory of Clinical Research
mi
from
Coral Gables, FL
Parkinson's Autonomic Responses to Treadmill Walking
Assessment of Autonomic Function and Cardiovascular Response to Exercise Testing in Parkinson's Disease Patients
Status: Enrolling
Updated: 12/31/1969
Laboratory of Clinical Research
mi
from
Coral Gables, FL
Click here to add this to my saved trials
Training and Parkinson's
The Comparative Impacts of Power Training and Strength Training Programs on Neuromuscular Performance and Other Physical Measurements in Individuals With Parkinson's Disease
Status: Enrolling
Updated:  12/31/1969
Max Orovitz Laboratories
mi
from
Coral Gables, FL
Training and Parkinson's
The Comparative Impacts of Power Training and Strength Training Programs on Neuromuscular Performance and Other Physical Measurements in Individuals With Parkinson's Disease
Status: Enrolling
Updated: 12/31/1969
Max Orovitz Laboratories
mi
from
Coral Gables, FL
Click here to add this to my saved trials
A Study Evaluating Potential Screening Tools for Detecting Parkinson Disease
Parkinson Associated Risk Factor Study (PARS): Evaluating Potential Screening Tools for Parkinson Disease
Status: Enrolling
Updated:  12/31/1969
The Institute for Neurodegenerative Disorders
mi
from
New Haven, CT
A Study Evaluating Potential Screening Tools for Detecting Parkinson Disease
Parkinson Associated Risk Factor Study (PARS): Evaluating Potential Screening Tools for Parkinson Disease
Status: Enrolling
Updated: 12/31/1969
The Institute for Neurodegenerative Disorders
mi
from
New Haven, CT
Click here to add this to my saved trials
Proprioception and Meditation
The Effects of Yoga Based Meditation on Proprioception in Individuals With Parkinson's Disease
Status: Enrolling
Updated:  12/31/1969
Laboratory of Neruomuscular Research and Active Aging
mi
from
Coral Gables, FL
Proprioception and Meditation
The Effects of Yoga Based Meditation on Proprioception in Individuals With Parkinson's Disease
Status: Enrolling
Updated: 12/31/1969
Laboratory of Neruomuscular Research and Active Aging
mi
from
Coral Gables, FL
Click here to add this to my saved trials
FoxBioNet Pilot Project: SAVE (Synuclein Assay Validation Effort)
FoxBioNet Pilot Project: SAVE (Synuclein Assay Validation Effort) (SAVE001)
Status: Enrolling
Updated:  12/31/1969
Rush University Medical Center
mi
from
Chicago, IL
FoxBioNet Pilot Project: SAVE (Synuclein Assay Validation Effort)
FoxBioNet Pilot Project: SAVE (Synuclein Assay Validation Effort) (SAVE001)
Status: Enrolling
Updated: 12/31/1969
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
FoxBioNet Pilot Project: SAVE (Synuclein Assay Validation Effort)
FoxBioNet Pilot Project: SAVE (Synuclein Assay Validation Effort) (SAVE001)
Status: Enrolling
Updated:  12/31/1969
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
FoxBioNet Pilot Project: SAVE (Synuclein Assay Validation Effort)
FoxBioNet Pilot Project: SAVE (Synuclein Assay Validation Effort) (SAVE001)
Status: Enrolling
Updated: 12/31/1969
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
FoxBioNet Pilot Project: SAVE (Synuclein Assay Validation Effort)
FoxBioNet Pilot Project: SAVE (Synuclein Assay Validation Effort) (SAVE001)
Status: Enrolling
Updated:  12/31/1969
Oregon Health and Sciences University
mi
from
Portland, OR
FoxBioNet Pilot Project: SAVE (Synuclein Assay Validation Effort)
FoxBioNet Pilot Project: SAVE (Synuclein Assay Validation Effort) (SAVE001)
Status: Enrolling
Updated: 12/31/1969
Oregon Health and Sciences University
mi
from
Portland, OR
Click here to add this to my saved trials
FoxBioNet Pilot Project: SAVE (Synuclein Assay Validation Effort)
FoxBioNet Pilot Project: SAVE (Synuclein Assay Validation Effort) (SAVE001)
Status: Enrolling
Updated:  12/31/1969
Univ of Pennsylvania
mi
from
Philadelphia, PA
FoxBioNet Pilot Project: SAVE (Synuclein Assay Validation Effort)
FoxBioNet Pilot Project: SAVE (Synuclein Assay Validation Effort) (SAVE001)
Status: Enrolling
Updated: 12/31/1969
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
FoxBioNet Pilot Project: SAVE (Synuclein Assay Validation Effort)
FoxBioNet Pilot Project: SAVE (Synuclein Assay Validation Effort) (SAVE001)
Status: Enrolling
Updated:  12/31/1969
Baylor College of Medicine
mi
from
Houston, TX
FoxBioNet Pilot Project: SAVE (Synuclein Assay Validation Effort)
FoxBioNet Pilot Project: SAVE (Synuclein Assay Validation Effort) (SAVE001)
Status: Enrolling
Updated: 12/31/1969
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Safety and Efficacy of DA-9805 for Parkinson's Disease
A Phase IIa, Randomized, Multicenter, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of DA-9805 in Subjects With Parkinson's Disease
Status: Enrolling
Updated:  12/31/1969
HealthPartners Institute
mi
from
Bloomington, MN
Safety and Efficacy of DA-9805 for Parkinson's Disease
A Phase IIa, Randomized, Multicenter, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of DA-9805 in Subjects With Parkinson's Disease
Status: Enrolling
Updated: 12/31/1969
HealthPartners Institute
mi
from
Bloomington, MN
Click here to add this to my saved trials
A Study in Subjects With Parkinson's Disease to Evaluate the Safety and Tolerability of Titration and Continuous Subcutaneous Infusion of ABBV-951 in an Outpatient Environment
An Open-Label Study in Subjects With Parkinson's Disease to Evaluate the Safety and Tolerability of Titration and Continuous Subcutaneous Infusion of ABBV-951 for up to 4 Weeks in an Outpatient Environment
Status: Enrolling
Updated:  12/31/1969
Banner Sun Health Res Inst /ID# 165840
mi
from
Sun City, AZ
A Study in Subjects With Parkinson's Disease to Evaluate the Safety and Tolerability of Titration and Continuous Subcutaneous Infusion of ABBV-951 in an Outpatient Environment
An Open-Label Study in Subjects With Parkinson's Disease to Evaluate the Safety and Tolerability of Titration and Continuous Subcutaneous Infusion of ABBV-951 for up to 4 Weeks in an Outpatient Environment
Status: Enrolling
Updated: 12/31/1969
Banner Sun Health Res Inst /ID# 165840
mi
from
Sun City, AZ
Click here to add this to my saved trials
A Study in Subjects With Parkinson's Disease to Evaluate the Safety and Tolerability of Titration and Continuous Subcutaneous Infusion of ABBV-951 in an Outpatient Environment
An Open-Label Study in Subjects With Parkinson's Disease to Evaluate the Safety and Tolerability of Titration and Continuous Subcutaneous Infusion of ABBV-951 for up to 4 Weeks in an Outpatient Environment
Status: Enrolling
Updated:  12/31/1969
Loma Linda University /ID# 165592
mi
from
Loma Linda, CA
A Study in Subjects With Parkinson's Disease to Evaluate the Safety and Tolerability of Titration and Continuous Subcutaneous Infusion of ABBV-951 in an Outpatient Environment
An Open-Label Study in Subjects With Parkinson's Disease to Evaluate the Safety and Tolerability of Titration and Continuous Subcutaneous Infusion of ABBV-951 for up to 4 Weeks in an Outpatient Environment
Status: Enrolling
Updated: 12/31/1969
Loma Linda University /ID# 165592
mi
from
Loma Linda, CA
Click here to add this to my saved trials
A Study in Subjects With Parkinson's Disease to Evaluate the Safety and Tolerability of Titration and Continuous Subcutaneous Infusion of ABBV-951 in an Outpatient Environment
An Open-Label Study in Subjects With Parkinson's Disease to Evaluate the Safety and Tolerability of Titration and Continuous Subcutaneous Infusion of ABBV-951 for up to 4 Weeks in an Outpatient Environment
Status: Enrolling
Updated:  12/31/1969
Univ CA, Irvine Med Ctr /ID# 165594
mi
from
Orange, CA
A Study in Subjects With Parkinson's Disease to Evaluate the Safety and Tolerability of Titration and Continuous Subcutaneous Infusion of ABBV-951 in an Outpatient Environment
An Open-Label Study in Subjects With Parkinson's Disease to Evaluate the Safety and Tolerability of Titration and Continuous Subcutaneous Infusion of ABBV-951 for up to 4 Weeks in an Outpatient Environment
Status: Enrolling
Updated: 12/31/1969
Univ CA, Irvine Med Ctr /ID# 165594
mi
from
Orange, CA
Click here to add this to my saved trials
A Study in Subjects With Parkinson's Disease to Evaluate the Safety and Tolerability of Titration and Continuous Subcutaneous Infusion of ABBV-951 in an Outpatient Environment
An Open-Label Study in Subjects With Parkinson's Disease to Evaluate the Safety and Tolerability of Titration and Continuous Subcutaneous Infusion of ABBV-951 for up to 4 Weeks in an Outpatient Environment
Status: Enrolling
Updated:  12/31/1969
Compass Research /ID# 167329
mi
from
Orlando, FL
A Study in Subjects With Parkinson's Disease to Evaluate the Safety and Tolerability of Titration and Continuous Subcutaneous Infusion of ABBV-951 in an Outpatient Environment
An Open-Label Study in Subjects With Parkinson's Disease to Evaluate the Safety and Tolerability of Titration and Continuous Subcutaneous Infusion of ABBV-951 for up to 4 Weeks in an Outpatient Environment
Status: Enrolling
Updated: 12/31/1969
Compass Research /ID# 167329
mi
from
Orlando, FL
Click here to add this to my saved trials
A Study in Subjects With Parkinson's Disease to Evaluate the Safety and Tolerability of Titration and Continuous Subcutaneous Infusion of ABBV-951 in an Outpatient Environment
An Open-Label Study in Subjects With Parkinson's Disease to Evaluate the Safety and Tolerability of Titration and Continuous Subcutaneous Infusion of ABBV-951 for up to 4 Weeks in an Outpatient Environment
Status: Enrolling
Updated:  12/31/1969
Univ Kansas Med Ctr /ID# 166280
mi
from
Kansas City, KA
A Study in Subjects With Parkinson's Disease to Evaluate the Safety and Tolerability of Titration and Continuous Subcutaneous Infusion of ABBV-951 in an Outpatient Environment
An Open-Label Study in Subjects With Parkinson's Disease to Evaluate the Safety and Tolerability of Titration and Continuous Subcutaneous Infusion of ABBV-951 for up to 4 Weeks in an Outpatient Environment
Status: Enrolling
Updated: 12/31/1969
Univ Kansas Med Ctr /ID# 166280
mi
from
Kansas City, KA
Click here to add this to my saved trials
A Study in Subjects With Parkinson's Disease to Evaluate the Safety and Tolerability of Titration and Continuous Subcutaneous Infusion of ABBV-951 in an Outpatient Environment
An Open-Label Study in Subjects With Parkinson's Disease to Evaluate the Safety and Tolerability of Titration and Continuous Subcutaneous Infusion of ABBV-951 for up to 4 Weeks in an Outpatient Environment
Status: Enrolling
Updated:  12/31/1969
University of Kentucky Chandler Medical Center /ID# 164407
mi
from
Lexington, KY
A Study in Subjects With Parkinson's Disease to Evaluate the Safety and Tolerability of Titration and Continuous Subcutaneous Infusion of ABBV-951 in an Outpatient Environment
An Open-Label Study in Subjects With Parkinson's Disease to Evaluate the Safety and Tolerability of Titration and Continuous Subcutaneous Infusion of ABBV-951 for up to 4 Weeks in an Outpatient Environment
Status: Enrolling
Updated: 12/31/1969
University of Kentucky Chandler Medical Center /ID# 164407
mi
from
Lexington, KY
Click here to add this to my saved trials
A Study in Subjects With Parkinson's Disease to Evaluate the Safety and Tolerability of Titration and Continuous Subcutaneous Infusion of ABBV-951 in an Outpatient Environment
An Open-Label Study in Subjects With Parkinson's Disease to Evaluate the Safety and Tolerability of Titration and Continuous Subcutaneous Infusion of ABBV-951 for up to 4 Weeks in an Outpatient Environment
Status: Enrolling
Updated:  12/31/1969
University of Louisville /ID# 164997
mi
from
Louisville, KY
A Study in Subjects With Parkinson's Disease to Evaluate the Safety and Tolerability of Titration and Continuous Subcutaneous Infusion of ABBV-951 in an Outpatient Environment
An Open-Label Study in Subjects With Parkinson's Disease to Evaluate the Safety and Tolerability of Titration and Continuous Subcutaneous Infusion of ABBV-951 for up to 4 Weeks in an Outpatient Environment
Status: Enrolling
Updated: 12/31/1969
University of Louisville /ID# 164997
mi
from
Louisville, KY
Click here to add this to my saved trials
A Study in Subjects With Parkinson's Disease to Evaluate the Safety and Tolerability of Titration and Continuous Subcutaneous Infusion of ABBV-951 in an Outpatient Environment
An Open-Label Study in Subjects With Parkinson's Disease to Evaluate the Safety and Tolerability of Titration and Continuous Subcutaneous Infusion of ABBV-951 for up to 4 Weeks in an Outpatient Environment
Status: Enrolling
Updated:  12/31/1969
Washington University-School of Medicine /ID# 164412
mi
from
Saint Louis, MO
A Study in Subjects With Parkinson's Disease to Evaluate the Safety and Tolerability of Titration and Continuous Subcutaneous Infusion of ABBV-951 in an Outpatient Environment
An Open-Label Study in Subjects With Parkinson's Disease to Evaluate the Safety and Tolerability of Titration and Continuous Subcutaneous Infusion of ABBV-951 for up to 4 Weeks in an Outpatient Environment
Status: Enrolling
Updated: 12/31/1969
Washington University-School of Medicine /ID# 164412
mi
from
Saint Louis, MO
Click here to add this to my saved trials
A Study in Subjects With Parkinson's Disease to Evaluate the Safety and Tolerability of Titration and Continuous Subcutaneous Infusion of ABBV-951 in an Outpatient Environment
An Open-Label Study in Subjects With Parkinson's Disease to Evaluate the Safety and Tolerability of Titration and Continuous Subcutaneous Infusion of ABBV-951 for up to 4 Weeks in an Outpatient Environment
Status: Enrolling
Updated:  12/31/1969
NYU Langone Medical Center /ID# 164924
mi
from
New York, NY
A Study in Subjects With Parkinson's Disease to Evaluate the Safety and Tolerability of Titration and Continuous Subcutaneous Infusion of ABBV-951 in an Outpatient Environment
An Open-Label Study in Subjects With Parkinson's Disease to Evaluate the Safety and Tolerability of Titration and Continuous Subcutaneous Infusion of ABBV-951 for up to 4 Weeks in an Outpatient Environment
Status: Enrolling
Updated: 12/31/1969
NYU Langone Medical Center /ID# 164924
mi
from
New York, NY
Click here to add this to my saved trials
A Study in Subjects With Parkinson's Disease to Evaluate the Safety and Tolerability of Titration and Continuous Subcutaneous Infusion of ABBV-951 in an Outpatient Environment
An Open-Label Study in Subjects With Parkinson's Disease to Evaluate the Safety and Tolerability of Titration and Continuous Subcutaneous Infusion of ABBV-951 for up to 4 Weeks in an Outpatient Environment
Status: Enrolling
Updated:  12/31/1969
University of Cincinnati /ID# 165142
mi
from
Cincinnati, OH
A Study in Subjects With Parkinson's Disease to Evaluate the Safety and Tolerability of Titration and Continuous Subcutaneous Infusion of ABBV-951 in an Outpatient Environment
An Open-Label Study in Subjects With Parkinson's Disease to Evaluate the Safety and Tolerability of Titration and Continuous Subcutaneous Infusion of ABBV-951 for up to 4 Weeks in an Outpatient Environment
Status: Enrolling
Updated: 12/31/1969
University of Cincinnati /ID# 165142
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Study in Subjects With Parkinson's Disease to Evaluate the Safety and Tolerability of Titration and Continuous Subcutaneous Infusion of ABBV-951 in an Outpatient Environment
An Open-Label Study in Subjects With Parkinson's Disease to Evaluate the Safety and Tolerability of Titration and Continuous Subcutaneous Infusion of ABBV-951 for up to 4 Weeks in an Outpatient Environment
Status: Enrolling
Updated:  12/31/1969
Cleveland Clinic Foundation /ID# 164413
mi
from
Cleveland, OH
A Study in Subjects With Parkinson's Disease to Evaluate the Safety and Tolerability of Titration and Continuous Subcutaneous Infusion of ABBV-951 in an Outpatient Environment
An Open-Label Study in Subjects With Parkinson's Disease to Evaluate the Safety and Tolerability of Titration and Continuous Subcutaneous Infusion of ABBV-951 for up to 4 Weeks in an Outpatient Environment
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic Foundation /ID# 164413
mi
from
Cleveland, OH
Click here to add this to my saved trials
A Study in Subjects With Parkinson's Disease to Evaluate the Safety and Tolerability of Titration and Continuous Subcutaneous Infusion of ABBV-951 in an Outpatient Environment
An Open-Label Study in Subjects With Parkinson's Disease to Evaluate the Safety and Tolerability of Titration and Continuous Subcutaneous Infusion of ABBV-951 for up to 4 Weeks in an Outpatient Environment
Status: Enrolling
Updated:  12/31/1969
Neurology Consultants of Dallas /ID# 167116
mi
from
Dallas, TX
A Study in Subjects With Parkinson's Disease to Evaluate the Safety and Tolerability of Titration and Continuous Subcutaneous Infusion of ABBV-951 in an Outpatient Environment
An Open-Label Study in Subjects With Parkinson's Disease to Evaluate the Safety and Tolerability of Titration and Continuous Subcutaneous Infusion of ABBV-951 for up to 4 Weeks in an Outpatient Environment
Status: Enrolling
Updated: 12/31/1969
Neurology Consultants of Dallas /ID# 167116
mi
from
Dallas, TX
Click here to add this to my saved trials
A Study of the Pharmacokinetics, Pharmacodynamics, and Safety of Opicapone in Subjects With Parkinson's Disease Taking Levodopa.
A Phase 1, Open-Label Study to Assess the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Repeated Doses of Opicapone, and Effect on Levodopa Pharmacokinetics in Subjects With Parkinson's Disease
Status: Enrolling
Updated:  12/31/1969
Neurocrine Clinical Site
mi
from
Glendale, CA
A Study of the Pharmacokinetics, Pharmacodynamics, and Safety of Opicapone in Subjects With Parkinson's Disease Taking Levodopa.
A Phase 1, Open-Label Study to Assess the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Repeated Doses of Opicapone, and Effect on Levodopa Pharmacokinetics in Subjects With Parkinson's Disease
Status: Enrolling
Updated: 12/31/1969
Neurocrine Clinical Site
mi
from
Glendale, CA
Click here to add this to my saved trials
A Study of the Pharmacokinetics, Pharmacodynamics, and Safety of Opicapone in Subjects With Parkinson's Disease Taking Levodopa.
A Phase 1, Open-Label Study to Assess the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Repeated Doses of Opicapone, and Effect on Levodopa Pharmacokinetics in Subjects With Parkinson's Disease
Status: Enrolling
Updated:  12/31/1969
Neurocrine Clinical Site
mi
from
Long Beach, CA
A Study of the Pharmacokinetics, Pharmacodynamics, and Safety of Opicapone in Subjects With Parkinson's Disease Taking Levodopa.
A Phase 1, Open-Label Study to Assess the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Repeated Doses of Opicapone, and Effect on Levodopa Pharmacokinetics in Subjects With Parkinson's Disease
Status: Enrolling
Updated: 12/31/1969
Neurocrine Clinical Site
mi
from
Long Beach, CA
Click here to add this to my saved trials
A Study of the Pharmacokinetics, Pharmacodynamics, and Safety of Opicapone in Subjects With Parkinson's Disease Taking Levodopa.
A Phase 1, Open-Label Study to Assess the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Repeated Doses of Opicapone, and Effect on Levodopa Pharmacokinetics in Subjects With Parkinson's Disease
Status: Enrolling
Updated:  12/31/1969
Neurocrine Clinical Site
mi
from
Farmington Hills, MI
A Study of the Pharmacokinetics, Pharmacodynamics, and Safety of Opicapone in Subjects With Parkinson's Disease Taking Levodopa.
A Phase 1, Open-Label Study to Assess the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Repeated Doses of Opicapone, and Effect on Levodopa Pharmacokinetics in Subjects With Parkinson's Disease
Status: Enrolling
Updated: 12/31/1969
Neurocrine Clinical Site
mi
from
Farmington Hills, MI
Click here to add this to my saved trials
The Use of Sensory or Motor Cues Using Electrical Stimulation to Reduce Gait Freezing in Patients With Parkinson Disease
The Use of Sensory or Motor Cues Using Electrical Stimulation to Reduce Gait Freezing in Patients With Parkinson Disease
Status: Enrolling
Updated:  12/31/1969
Washington University Program in Physical Therapy
mi
from
Saint Louis, MO
The Use of Sensory or Motor Cues Using Electrical Stimulation to Reduce Gait Freezing in Patients With Parkinson Disease
The Use of Sensory or Motor Cues Using Electrical Stimulation to Reduce Gait Freezing in Patients With Parkinson Disease
Status: Enrolling
Updated: 12/31/1969
Washington University Program in Physical Therapy
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Convection Enhanced Delivery of CSF in DBS for Parkinson's
Convection Enhanced Delivery of Autologous Cerebral Spinal Fluid Improves MRI Visualizations of Basal Ganglion Nuclei During Deep Brain Stimulation Surgery
Status: Enrolling
Updated:  12/31/1969
University of Virginia
mi
from
Charlottesville, VA
Convection Enhanced Delivery of CSF in DBS for Parkinson's
Convection Enhanced Delivery of Autologous Cerebral Spinal Fluid Improves MRI Visualizations of Basal Ganglion Nuclei During Deep Brain Stimulation Surgery
Status: Enrolling
Updated: 12/31/1969
University of Virginia
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Mild Cognitive Impairment and Endurance Exercise in Parkinson's Disease
Mild Cognitive Impairment and Endurance Exercise in Parkinson's Disease
Status: Enrolling
Updated:  12/31/1969
Northwestern University
mi
from
Chicago, IL
Mild Cognitive Impairment and Endurance Exercise in Parkinson's Disease
Mild Cognitive Impairment and Endurance Exercise in Parkinson's Disease
Status: Enrolling
Updated: 12/31/1969
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Kick Out Parkinson's Disease
Karate Intervention to Change Kinematic Outcomes in Parkinson's Disease
Status: Enrolling
Updated:  12/31/1969
Rush University Medical Center
mi
from
Chicago, IL
Kick Out Parkinson's Disease
Karate Intervention to Change Kinematic Outcomes in Parkinson's Disease
Status: Enrolling
Updated: 12/31/1969
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Effects of Droxidopa When Measuring Gait Speed, Kyphosis, and Functional Reach in Parkinson's Disease
Effects of Droxidopa When Measuring Gait Speed, Kyphosis, and Functional Reach in Parkinson's Disease
Status: Enrolling
Updated:  12/31/1969
Colorado Springs Neurological Associates
mi
from
Colorado Springs, CO
Effects of Droxidopa When Measuring Gait Speed, Kyphosis, and Functional Reach in Parkinson's Disease
Effects of Droxidopa When Measuring Gait Speed, Kyphosis, and Functional Reach in Parkinson's Disease
Status: Enrolling
Updated: 12/31/1969
Colorado Springs Neurological Associates
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Pharmacokinetic Study of LY03003 in Patients With Parkinson's Disease
An Open-label, Randomized, Parallel-group Trial to Evaluate the Pharmacokinetics of Two Formulations of LY03003 After a Single Intramuscular Injection Administered to Patients With Parkinson's Disease
Status: Enrolling
Updated:  12/31/1969
MD Clinical
mi
from
Hallandale Beach, FL
Pharmacokinetic Study of LY03003 in Patients With Parkinson's Disease
An Open-label, Randomized, Parallel-group Trial to Evaluate the Pharmacokinetics of Two Formulations of LY03003 After a Single Intramuscular Injection Administered to Patients With Parkinson's Disease
Status: Enrolling
Updated: 12/31/1969
MD Clinical
mi
from
Hallandale Beach, FL
Click here to add this to my saved trials
Pharmacokinetic Study of LY03003 in Patients With Parkinson's Disease
An Open-label, Randomized, Parallel-group Trial to Evaluate the Pharmacokinetics of Two Formulations of LY03003 After a Single Intramuscular Injection Administered to Patients With Parkinson's Disease
Status: Enrolling
Updated:  12/31/1969
Atlanta Center for Medical Research
mi
from
Atlanta, GA
Pharmacokinetic Study of LY03003 in Patients With Parkinson's Disease
An Open-label, Randomized, Parallel-group Trial to Evaluate the Pharmacokinetics of Two Formulations of LY03003 After a Single Intramuscular Injection Administered to Patients With Parkinson's Disease
Status: Enrolling
Updated: 12/31/1969
Atlanta Center for Medical Research
mi
from
Atlanta, GA
Click here to add this to my saved trials
Clinical Evaluation of the Infinity DBS System
Post Market Clinical Follow Up Evaluating the Infinity Deep Brain Stimulation Implantable Pulse Generator System
Status: Enrolling
Updated:  12/31/1969
Kaiser Permanente Sacramento Medical Center
mi
from
Sacramento, CA
Clinical Evaluation of the Infinity DBS System
Post Market Clinical Follow Up Evaluating the Infinity Deep Brain Stimulation Implantable Pulse Generator System
Status: Enrolling
Updated: 12/31/1969
Kaiser Permanente Sacramento Medical Center
mi
from
Sacramento, CA
Click here to add this to my saved trials
Clinical Evaluation of the Infinity DBS System
Post Market Clinical Follow Up Evaluating the Infinity Deep Brain Stimulation Implantable Pulse Generator System
Status: Enrolling
Updated:  12/31/1969
University of Colorado Hospital
mi
from
Aurora, CO
Clinical Evaluation of the Infinity DBS System
Post Market Clinical Follow Up Evaluating the Infinity Deep Brain Stimulation Implantable Pulse Generator System
Status: Enrolling
Updated: 12/31/1969
University of Colorado Hospital
mi
from
Aurora, CO
Click here to add this to my saved trials
Clinical Evaluation of the Infinity DBS System
Post Market Clinical Follow Up Evaluating the Infinity Deep Brain Stimulation Implantable Pulse Generator System
Status: Enrolling
Updated:  12/31/1969
Shands at the University of Florida
mi
from
Gainesville, FL
Clinical Evaluation of the Infinity DBS System
Post Market Clinical Follow Up Evaluating the Infinity Deep Brain Stimulation Implantable Pulse Generator System
Status: Enrolling
Updated: 12/31/1969
Shands at the University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
Clinical Evaluation of the Infinity DBS System
Post Market Clinical Follow Up Evaluating the Infinity Deep Brain Stimulation Implantable Pulse Generator System
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic, Jacksonville
mi
from
Jacksonville, FL
Clinical Evaluation of the Infinity DBS System
Post Market Clinical Follow Up Evaluating the Infinity Deep Brain Stimulation Implantable Pulse Generator System
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic, Jacksonville
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Clinical Evaluation of the Infinity DBS System
Post Market Clinical Follow Up Evaluating the Infinity Deep Brain Stimulation Implantable Pulse Generator System
Status: Enrolling
Updated:  12/31/1969
University of Miami Hospital
mi
from
Miami, FL
Clinical Evaluation of the Infinity DBS System
Post Market Clinical Follow Up Evaluating the Infinity Deep Brain Stimulation Implantable Pulse Generator System
Status: Enrolling
Updated: 12/31/1969
University of Miami Hospital
mi
from
Miami, FL
Click here to add this to my saved trials
Clinical Evaluation of the Infinity DBS System
Post Market Clinical Follow Up Evaluating the Infinity Deep Brain Stimulation Implantable Pulse Generator System
Status: Enrolling
Updated:  12/31/1969
Rush University Medical Center
mi
from
Chicago, IL
Clinical Evaluation of the Infinity DBS System
Post Market Clinical Follow Up Evaluating the Infinity Deep Brain Stimulation Implantable Pulse Generator System
Status: Enrolling
Updated: 12/31/1969
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Clinical Evaluation of the Infinity DBS System
Post Market Clinical Follow Up Evaluating the Infinity Deep Brain Stimulation Implantable Pulse Generator System
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins University Hospital
mi
from
Baltimore, MD
Clinical Evaluation of the Infinity DBS System
Post Market Clinical Follow Up Evaluating the Infinity Deep Brain Stimulation Implantable Pulse Generator System
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins University Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
Clinical Evaluation of the Infinity DBS System
Post Market Clinical Follow Up Evaluating the Infinity Deep Brain Stimulation Implantable Pulse Generator System
Status: Enrolling
Updated:  12/31/1969
Albany Medical College at Albany Medical Center
mi
from
Albany, NY
Clinical Evaluation of the Infinity DBS System
Post Market Clinical Follow Up Evaluating the Infinity Deep Brain Stimulation Implantable Pulse Generator System
Status: Enrolling
Updated: 12/31/1969
Albany Medical College at Albany Medical Center
mi
from
Albany, NY
Click here to add this to my saved trials
Clinical Evaluation of the Infinity DBS System
Post Market Clinical Follow Up Evaluating the Infinity Deep Brain Stimulation Implantable Pulse Generator System
Status: Enrolling
Updated:  12/31/1969
New York University Langone Medical Center - Tisch Hospital
mi
from
New York, NY
Clinical Evaluation of the Infinity DBS System
Post Market Clinical Follow Up Evaluating the Infinity Deep Brain Stimulation Implantable Pulse Generator System
Status: Enrolling
Updated: 12/31/1969
New York University Langone Medical Center - Tisch Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Clinical Evaluation of the Infinity DBS System
Post Market Clinical Follow Up Evaluating the Infinity Deep Brain Stimulation Implantable Pulse Generator System
Status: Enrolling
Updated:  12/31/1969
Mount Sinai Hosp
mi
from
New York, NY
Clinical Evaluation of the Infinity DBS System
Post Market Clinical Follow Up Evaluating the Infinity Deep Brain Stimulation Implantable Pulse Generator System
Status: Enrolling
Updated: 12/31/1969
Mount Sinai Hosp
mi
from
New York, NY
Click here to add this to my saved trials
Clinical Evaluation of the Infinity DBS System
Post Market Clinical Follow Up Evaluating the Infinity Deep Brain Stimulation Implantable Pulse Generator System
Status: Enrolling
Updated:  12/31/1969
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Clinical Evaluation of the Infinity DBS System
Post Market Clinical Follow Up Evaluating the Infinity Deep Brain Stimulation Implantable Pulse Generator System
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
Clinical Evaluation of the Infinity DBS System
Post Market Clinical Follow Up Evaluating the Infinity Deep Brain Stimulation Implantable Pulse Generator System
Status: Enrolling
Updated:  12/31/1969
Oregon Health and Science University
mi
from
Portland, OR
Clinical Evaluation of the Infinity DBS System
Post Market Clinical Follow Up Evaluating the Infinity Deep Brain Stimulation Implantable Pulse Generator System
Status: Enrolling
Updated: 12/31/1969
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Clinical Evaluation of the Infinity DBS System
Post Market Clinical Follow Up Evaluating the Infinity Deep Brain Stimulation Implantable Pulse Generator System
Status: Enrolling
Updated:  12/31/1969
St Luke'S Hospital And Health Network
mi
from
Bethlehem, PA
Clinical Evaluation of the Infinity DBS System
Post Market Clinical Follow Up Evaluating the Infinity Deep Brain Stimulation Implantable Pulse Generator System
Status: Enrolling
Updated: 12/31/1969
St Luke'S Hospital And Health Network
mi
from
Bethlehem, PA
Click here to add this to my saved trials
Clinical Evaluation of the Infinity DBS System
Post Market Clinical Follow Up Evaluating the Infinity Deep Brain Stimulation Implantable Pulse Generator System
Status: Enrolling
Updated:  12/31/1969
Pennsylvania Hospital
mi
from
Philadelphia, PA
Clinical Evaluation of the Infinity DBS System
Post Market Clinical Follow Up Evaluating the Infinity Deep Brain Stimulation Implantable Pulse Generator System
Status: Enrolling
Updated: 12/31/1969
Pennsylvania Hospital
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Clinical Evaluation of the Infinity DBS System
Post Market Clinical Follow Up Evaluating the Infinity Deep Brain Stimulation Implantable Pulse Generator System
Status: Enrolling
Updated:  12/31/1969
Thomas Jefferson University Hospital
mi
from
Philadelphia, PA
Clinical Evaluation of the Infinity DBS System
Post Market Clinical Follow Up Evaluating the Infinity Deep Brain Stimulation Implantable Pulse Generator System
Status: Enrolling
Updated: 12/31/1969
Thomas Jefferson University Hospital
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Clinical Evaluation of the Infinity DBS System
Post Market Clinical Follow Up Evaluating the Infinity Deep Brain Stimulation Implantable Pulse Generator System
Status: Enrolling
Updated:  12/31/1969
Allegheny Singer Research Institute
mi
from
Pittsburgh, PA
Clinical Evaluation of the Infinity DBS System
Post Market Clinical Follow Up Evaluating the Infinity Deep Brain Stimulation Implantable Pulse Generator System
Status: Enrolling
Updated: 12/31/1969
Allegheny Singer Research Institute
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Clinical Evaluation of the Infinity DBS System
Post Market Clinical Follow Up Evaluating the Infinity Deep Brain Stimulation Implantable Pulse Generator System
Status: Enrolling
Updated:  12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
Clinical Evaluation of the Infinity DBS System
Post Market Clinical Follow Up Evaluating the Infinity Deep Brain Stimulation Implantable Pulse Generator System
Status: Enrolling
Updated: 12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials